兔多克隆抗体to Flt3 / CD135 - Carboxyterminal end
Synthetic peptide corresponding to Human Flt3/ CD135 (C terminal) conjugated to Keyhole Limpet Haemocyanin (KLH).
- 293 cell lysate
Human breast carcinoma tissue
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Protein G purified
This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/100 - 1/500. Detects a band of approximately 113 kDa (predicted molecular weight: 113 kDa).
||1/50 - 1/100.
Receptor for the FL cytokine. Has a tyrosine-protein kinase activity.
Bone marrow cells.
Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
Contains 1 Ig-like C2-type (immunoglobulin-like) domain.
Contains 1 protein kinase domain.
Information by UniProt
- CD 135 antibody
- CD135 antibody
- CD135 antigen antibody
Western blot - Flt3 / CD135 antibody (ab71771)
Anti-Flt3 / CD135 antibody - Carboxyterminal end (ab71771) at 1/100 dilution + 293 cell lysate at 12.5 µg
Anti rabbit HRP
Developed using the ECL technique
Predicted band size : 113 kDa
Observed band size : 113 kDa
Additional bands at : 35 kDa,49 kDa,74 kDa. We are unsure as to the identity of these extra bands.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Flt3 / CD135 antibody (ab71771)
Formalin-fixed and paraffin-embedded human breast carcinoma tissue labelled with ab71771 at 1/50 dilution followed by use of a peroxidase-conjugated secondary antibody and AEC staining.
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"